|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/445 | |
| A61K 31/40 | |||
| A61K 31/485 | |||
| A61K 31/135 | |||
| A61P 3/04 |
| (11) | Number of the document | 1505974 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03752716.5 |
| Date of filing the European patent application | 2003-04-28 | |
| (97) | Date of publication of the European application | 2005-02-16 |
| (45) | Date of publication and mention of the grant of the patent | 2009-04-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2003/004428 |
| Date | 2003-04-28 |
| (87) | Number | WO 2003/097051 |
| Date | 2003-11-27 |
| (30) | Number | Date | Country code |
| 02011047 | 2002-05-17 | EP |
| (72) |
WEBER, Frank, DE
JACOB, Jutta, DE
BARBER, Andrew, DE
GOTTSCHLICH, Rudolf, DE
|
| (73) |
Tioga Pharmaceuticals, Inc.,
c/o Forward Ventures 9393 Towne Centre Dr. Suite 200, San Diego, CA 92121,
US
|
| (54) | USE OF COMPOUNDS THAT ARE EFFECTIVE AS SELECTIVE OPIATE RECEPTOR MODULATORS |
| USE OF COMPOUNDS THAT ARE EFFECTIVE AS SELECTIVE OPIATE RECEPTOR MODULATORS |